e-Clinical Solutions Market (By Product: Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), Clinical Analytics Platforms, Randomization and Trial Supply Management (RTSM) , Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment (eCOA), Safety Solutions, Electronic Trial Master File (eTMF); By Delivery Mode: Web-hosted, Licensed Enterprise, Cloud-based; By Development Phase: Phase I, Phase II, Phase III, Phase IV; By End-use: Hospitals/Healthcare providers, CROs, Academic Institutes, Pharma & Biotech Organizations, Medical Device Manufacturers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Development Phase Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global E-Clinical Solutions Market, By Product

7.1.  E-Clinical Solutions Market, by Product, 2021-2030

7.1.1.    Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Clinical Trial Management Systems (CTMS)

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Clinical Analytics Platforms

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Randomization and Trial Supply Management (RTSM)

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    Clinical Data Integration Platforms

7.1.5.1.        Market Revenue and Forecast (2017-2030)

7.1.6.    Electronic Clinical Outcome Assessment (eCOA)S)

7.1.6.1.        Market Revenue and Forecast (2017-2030)

7.1.7.    Safety Solutions

7.1.7.1.        Market Revenue and Forecast (2017-2030)

7.1.8.    Electronic Trial Master File (eTMF)

7.1.8.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global E-Clinical Solutions Market, By Delivery Mode

8.1.  E-Clinical Solutions Market, by Delivery Mode, 2021-2030

8.1.1.    Web-hosted (On demand)

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Licensed Enterprise (On premise)

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Cloud-based

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global E-Clinical Solutions Market, By Development Phase

9.1.  E-Clinical Solutions Market, by Development Phase, 2021-2030

9.1.1.    Phase I

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Phase II

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Phase III

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Phase IV

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global E-Clinical Solutions Market, By End-user

10.1.        E-Clinical Solutions Market, by End-user, 2021-2030

10.1.1.  Hospitals/Healthcare providers

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  CROs

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Academic Institutes

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Pharma & Biotech Organizations

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Medical Device Manufacturers

10.1.5.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global E-Clinical Solutions Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2017-2030)

11.1.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.1.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.1.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2017-2030)

11.2.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2017-2030)

11.3.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2017-2030)

11.4.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2017-2030)

11.5.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.5.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.5.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

Chapter 12.  Company Profiles

12.1.              Datatrak International, Inc.

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Oracle

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Parexel International Corporation

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Dassault Systemes

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Bioclinica

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Datatrak International, Inc.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              CRF Health

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              ERT Clinical

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              eClinicalWorks

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           IBM

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms